CD8A and neoplasm: An increase was noted in CD8 + peripheralblood cells (1.7 ± 0.12% in the R10 group versus4.56 ± 1.06% in the control group, p<0.05,Fig 3B), which was concomitant with a reductionin tumor size (Fig 3C).